|
Phase I
A Phase I Study of Bevacizumab in Combination with SU11248
Phase I
Study of Capecitabine (Xeloda) and Radiation Therapy in Patients with
Locally Advanced Cervical and Pelvic Malignancies
A Phase
IB Study in Patients with Metastatic Colorectal Cancer to Evaluate
Pharmacodynamic Effects of Erlotinib and Safety and Efficacy of Erlotinib
in Combination with FOLFOX6
Phase I Clinical Trial Using Topical Silicon
Phthalocyanine (Pc 4) Photodynamic Therapy (PDT) for the
Treatment of Pre-Malignant and Malignant Skin Conditions
-
CASE
2Y04
Phase I Trial of Daily Lenalidomide (CC-5013, Revlimid™) and Docetaxel Given Every Three Weeks in Patients with Advanced Solid Tumors.
-
S
0355
A Phase I Pharmacokinetic Study of Epothilone B Analogue BMS-247550 (NSC-710428D) in Patients with Advanced Malignancies and Varying Levels of Liver Dysfunction
-
GLAX
1Y04
An
Open Label, Phase Ib Roll-Over Study to Assess the Long-Term Safety
Profile of Lapatinib in Cancer Patients
A Phase I
Pharmacokinetic Study of PS-341 in Patients with Advanced Malignancies and
Varying Degrees of Liver Dysfunction for the CTEP-Sponsored Organ
Dysfunction Working Group
(Temporarily
Suspended)
A Phase I Trial of PS-341 and Fludarabine for Relapsed and
Refractory Indolent Non-Hodgkin's Lymphoma and Chronic
Lymphocytic Leukemia
UWCC
1Y03
A Phase I Pharmacokinetic Study of PS-341 in Patients with
Advanced Malignancies and Varying Degrees of Renal
Dysfunction for the CTEP-Sponsored Organ Dysfunction Working
Group
CWRU
1301 (Suspended)
A
Phase I Study of the Epidermal Growth Factor Receptor
Tyrosine Kinase Inhibitor, OSI-774, in Combination with
Docetaxel and Radiation in Locally Advanced Squamous Cell
Cancer of the Head and Neck
CWRU
2Y97
Mutant
MGM Gene Transfer Into Human Hematopoietic Progenitors to
Protect Hematopoiesis During O6-Benzylguanine (BG)
and BCNU Therapy of Advanced Solid Tumors
-
PFIZ
1Y03 (Suspended)
A Multicenter, Open Label, Noncomparative Phase I-II Clinical and Pharmacokinetic Study of Oral PD0325901 in Patients with Advanced Cancer
-
E
2A01 (Suspended)
A Phase I Study of Amifostine Followed by High-Dose Escalation of Melphalan with Stem Cell Reconstitution for Patients with Primary Systemic Amyloidosis
-
UPCI
1Y03
A Phase I Study of 17-DIMETHYLAMINOETHYLAMINO-17-DEMETHOXYGELDANAMYCIN (17-DMAG) in Patients with Advanced Solid Tumors
-
WAGM
1Y04
Phase I Dose Escalation Study of Oral SKI-606 in Subjects with Advanced Malignant Solid Tumors
-
CASE
3904
Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias
-
CWRU
6Y02
11C Topotecan PET Imaging
|
|
